This report analyzes the worldwide markets for Chiral Technology in US$ Million by the following Chiral Technology Enabling Products - Intermediates, Analytical, and Others. The End Use markets also analyzed in the report include Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as Albemarle Corporation, BASF SE, Cambrex Corp., Chiral Quest Inc., Dalco ChromTech AB, Daicel Corporation., Chiral Technologies, Inc., Chiral Technologies Europe, DSM Pharmaceutical Products, Johnson Matthey PLC, Regis Technologies Inc., Shasun Pharmaceuticals Limited, Solvias, Sigma Aldrich Corp, and Suven Life Sciences Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Table of Contents
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Chiral Technology Enabling Products
Chiral Intermediates
Analytical Products
Other Products
Chiral Technology End-Use Markets
Pharmaceuticals
Agrochemicals
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Bright Outlook for the Global Chiral Technology Market
Table 1: World Chiral Technology Enabling Products Market by Segment (2011): Percentage Share Breakdown by Value Sales for Chiral Intermediates, Chiral Analytical Products, and Others (includes corresponding Graph/Chart)
Good Tidings for Chiral Technology
Market Drivers
Demand for Chiral-based Therapeutic Drugs Augments Growth
New Legislations Push Chiral Technology Demand
Key Market Trends
Organizations Extend Approaches
Companies' Association with Universities
Trends in Chiral Processes
Increasing Reliance on Generic Approaches
Predominant Use of Polysaccharides Derivatives as CSPs
Automation: Introduction of Instruments Supporting Chiral Processes, a Growing Trend
2. CHIRAL TECHNOLOGY
An Insight into Chiral Technology
Techniques Used for Achieving Single-Isomers
Table 2: World Chiral Technology Market (2011): Percentage Breakdown of Revenues by Techniques- Traditional Methods, Asymmetric Methods, and Biological Methods (includes corresponding Graph/Chart)
Importance and Advancements
3. CHIRAL TECHNOLOGY - AN OVERVIEW
Definitions
Chiral Technology Enabling Products
Chiral Intermediates
Analytical Products
Other Products
Chiral Technology End-Use Markets
Pharmaceuticals
Agrochemicals
Description
Functioning of Chiral Molecules
Chiral Preparation Process
Traditional Methods
Biological Methods
Asymmetric Methods
Chiral Separation
Factors Influencing the Efficacy of Chiral Separations
Recent Approaches in Chiral Separations
Extensive Use of Supercritical Fluid Chromatography (SFC)
Chromatography - The Widely Used Method for Separation
How it Works?
Chiral Mobile Phase Additive (CMPA)
Chiral Stationary Phase (CSP)
List of Newly Introduced Generic Versions of Derivatized Amylose and Cellulose Phases
Challenges and Novel Concepts in the Development of Chiral Stationary Phases
Novel Concepts
Chiral Recognition
Protein Chiral Stationary Phases
Carbohydrate Columns
Pirkle Columns
Crystallization
Solvent Extraction
Kinetic Resolution
Capillary Electrophoresis
Receptor Based Resolution
Miscellaneous Separative Techniques
Chiral Synthesis
4. CHIRAL TECHNOLOGY - DEVELOPMENT VIS-A-VIS ACQUISITION
In-House Creation & Development
Acquisition of Technology
"Economics" of Chiral Technology
5. CHIRAL ANALYSIS
Chiral Analysis: A Primer
Chiral Analysis Products
Chiral Analytical Chromatography
Chiral Liquid Chromatography
Supercritical Fluid Chromatography - Substitute to LC for Enantiomer Separations
Chiral Gas Chromatography
Chiral Simulated Moving Bed Chromatography
Partition Chromatography
Adsorption Chromatography
Computer Assisted Resolution
Chiral Polarimetry
Other Chiral Analytical Techniques
Calorimetry
Differential Scanning Calorimetry (DSC)
Enzymatic Assay
Immunoassay
Isotope Dilution
Nuclear Magnetic Resonance (NMR)
X-Ray Crystallography
6. APPLICATION MARKETS
Pharmaceuticals - The Largest Market
Changing Face of the Pharmaceutical Industry: A Review
Analysis of Chiral Drugs
Select Companies Involved in Chiral Technology Market
Single-Enantiomer Drugs Worldwide
Drugs Built on Chiral Technology
Analgesics
Anesthetics
Anti-Infective Products
Cardiovascular System (CVS) Products
Angiotensin-Converting Enzyme (ACE) Inhibitors
Beta-Blockers
Calcium Channel Blockers
Diuretics
Vasodilators
Central Nervous System (CNS) Agents
Anticonvulsants
Sedatives and Tranquilizers
Stimulants and Antidepressants
Oncogenic (Cancer-Treatment) Products
Biochemicals
Oligonucleotides
Oxyacids
Amino Acids
Sugars and Other Oligosaccharides
Vitamins
Peptides
Pesticides - A Thriving Market
Herbicides
Insecticides
Fungicides
Other Products
Liquid Crystals
Flavor and Aroma Chemicals
7. CHIRAL ISOMERISM
Organic Chemical Isomerism Types
Structural Isomerism
Chain Isomerism
Position Isomerism
Functional Group Isomerism
Stereoisomerism
Dynamic Isomerism (Tautomerism)
Patents
8. REGULATORY & ENVIRONMENTAL ISSUES - A REVIEW
9. PRODUCT INTRODUCTIONS/INNOVATIONS
Phenomenex Introduces Chiral Screening Service
AminoLogics Develops a Novel Chiral Converting Molecule for Amino Acids
Chiral Technologies Worldwide to Display 3-im and Protein-based Reversed Phase Columns
Chiral Technologies Introduces 3µm Chiral Stationary Phases for Rapid Analysis
Chiral Technologies Introduces 5µm Versions of Polysaccharide-Based Chiral Stationary
Semba Launches Semba Octave(tm) Chromatography System
Modular SFC to Launch Chiral Centrifugal Fraction Collector and Sample Concentration System
Chiral Technologies Introduces New Versions of Immobilized IC and IA Chiral Phases
PDR-Chiral Develops AutoMDS for Automated Screening of Chiral and Achiral Substances
10. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER
Waters Introduces New Products Under the UPLC Line
Daicel Chemical Industries Announces Renaming to Daicel Corp.
WR Grace Takes Over Synthetech
Daicel Chiral to Start a New Branch in Beijing
Saltigo Concludes Process Development Agreement with Reuter Chemische
Chiral Technologies Europe Inks Global Licensing Agreement with University of Vienna
Shasun Announces Change of Name
CT Worldwide Announces the Launch of a Novel Microsite
Chiral Technologies Partners with Vanderbilt University's Program in Drug Discovery
DSM Renews Co-Operation Agreement with Fudan University
Chiral Technologies Europe Inks Distribution Agreement with HICHROM
12. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER
Dow Sells Dowpharma Small Molecules Business
Daicel Chemical Establishes New Subsidiary in China
Chiral Technologies Europe Takes Over ChromTech
Cambrex to Buy ProSyntest AS
Johnson Matthey and X-Zyme Sign Licensing Agreement
Chiral Quest Starts a New Production Facility
Chiral Quest Completes Reverse Merger with Surg II
DSM and IEP Extend Partnership
Shasun Chemicals Acquires Rhodia Pharma Solutions
Sigma-Aldrich Corp Acquires Astec
Solvias Receives License for MeOBIPHEP Catalyst Technology
Codexis Acquires Juelich Fine Chemicals
13. FOCUS ON SELECT PLAYERS
Albemarle Corporation (USA)
BASF SE (Germany)
Cambrex Corp. (USA)
Chiral Quest Inc. (US)
Dalco ChromTech AB (Sweden)
Daicel Corporation (Japan)
Chiral Technologies Worldwide
Chiral Technologies, Inc. (USA)
Chiral Technologies Europe (France)
DSM Pharmaceutical Products (The Netherlands)
Johnson Matthey PLC (UK)
Regis Technologies, Inc. (USA)
Shasun Pharmaceuticals Limited (India)
Solvias (Switzerland)
Sigma Aldrich Corp. (USA)
Suven Life Sciences Ltd. (USA)
14. GLOBAL MARKET PERSPECTIVE
Table 3: World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 4: World Historic Review for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 5: World 15-Year Perspective for Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 6: World Recent Past, Current & Future Analysis for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 7: World Historic Review for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 8: World 15-Year Perspective for Chiral Intermediates by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 9: World Recent Past, Current & Future Analysis for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 10: World Historic Review for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 11: World 15-Year Perspective for Chiral Analytical Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 12: World Recent Past, Current & Future Analysis for Other* Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Other* Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 14: World 15-Year Perspective for Other* Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 15: World Recent Past, Current & Future Analysis for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 16: World Historic Review for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 17: World 15-Year Perspective for Chiral Technology in Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current & Future Analysis for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 20: World 15-Year Perspective for Chiral Technology in Agrochemicals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
A. Market Analysis
Overview
B. Market Analytics
Table 21: The US Recent Past, Current and Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 22: The US Historic Review for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 23: The US 15-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 24: The US Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 25: The US Historic Review for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 26: The US 15-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2. JAPAN
Market Analytics
Table 27: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 28: Japanese Historic Review for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 29: Japanese 15-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 30: Japanese Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 31: Japanese Historic Review for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 32: Japanese 15-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals and Agrochemicals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
3. EUROPE
A. Market Analysis
Overview
B. Market Analytics
Table 33: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 34: European Historic Review for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 35: European 15-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 36: European Recent Past, Current and Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 37: European Historic Review for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 38: European 15-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4. REST OF WORLD
A. Market Analysis
India
Chiral Drugs in the Indian Market
China-A Hub for Pharmaceutical Manufacturing
B. Market Analytics
Table 39: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 40: Rest of World Historic Review for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 41: Rest of World 15-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 42: Rest of World Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 43: Rest of World Historic Review for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 44: Rest of World 15-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Chiral Technology published by Global Industry Analysts, Inc. in April 1, 2012. This report consists of Pages: 325 and the price starts from US $ 4500.
The contents of this page may be different from the latest version. Please contact us for details.
